Contact Us

Our website offers content and information on many specific areas of interest. If you have a general question which is not answered on our website, please contact us.

Bristol-Myers Squibb Pharmaceuticals Limited (Uxbridge)

BMS House
Uxbridge Business Park
Sanderson Road
Uxbridge
Middlesex
UB8 1DH

 

Fax: 01895 523010

Bristol-Myers Squibb Medical Information Hotline

(UK only freephone number)

Available 24 hours a day,
365 days a year, or contact us by email at

(international number)

Bristol-Myers Squibb Pharmaceuticals Limited
Pharmaceutical Research Institute (Moreton)

Reeds Lane
Moreton
CH46 1QW

 

Fax: 0151 5521702

Bristol-Myers Squibb Business Services Limited

Lakewood
Heronsway
Chester Business Park
Wrexham Road
Chester
CH4 9QW

 

Fax: 01244 5861007

Pharmacovigilance Notice

This website has not been designed to collect safety information related to Bristol-Myers Squibb products.

 

Healthcare Professionals: 
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Bristol-Myers Squibb Medical Information on 0800 731 1736 or medical.information@bms.com

 

Patients: 
Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Side effects should also be reported to Bristol-Myers Squibb Medical Information on 0800 731 1736 or medical.information@bms.com. By reporting side effects you can help provide more information on the safety of this medicine.

 

Healthcare professionals and patients should also report Product Quality Complaints to Bristol-Myers Squibb Medical Information on 0800 731 1736 or medical.information@bms.com


Date of preparation: May 2018; MLTUK1701479-01